A two-drug antihypertensive treatment that included a beta-blocker was associated with increased risk for major adverse cardiovascular events and death in a study of patients who underwent noncardiac surgery, according to an article.
A two-drug antihypertensive treatment that included a beta-blocker was associated with increased risk for major adverse cardiovascular events and death in a study of patients who underwent noncardiac surgery, according to an article.